Brainstorm Cell Therapeutics | BCLI - Current Liabilities


Brainstorm Cell Therapeutics reported $12.38M in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
Alterity Therapeutics Limited AUD 1.73M 2.77M Dec/2025
Biogen USD 3.92B 918.2M Jun/2026
Brainstorm Cell Therapeutics USD 12.38M 621K Jun/2026
Cipla INR 70.14B 7.16B Mar/2026
Clal Biotechnology ILS 6.66M 3.75M Dec/2023
Compugen USD 22.04M 533K Mar/2026
CSL USD 4.61B 207M Dec/2025
Cytokinetics USD 181.43M 17.76M Jun/2026
Gilead Sciences USD 11.02B 1.54B Jun/2026
Grifols EUR 2.37B 156.97M Dec/2025
Halozyme Therapeutics USD 344.44M 18.77M Jun/2026
Mesoblast USD 128.07M 25.44M Dec/2025